Trial Profile
Zotarolimus eluting stent verses GENOUS stent in patients with ST-elevation myocardial infarction undergoing primary PCI
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 20 Dec 2016
Price :
$35
*
At a glance
- Drugs Anti-CD34 monoclonal antibody (Primary) ; Zotarolimus (Primary)
- Indications Myocardial infarction
- Focus Therapeutic Use
- 20 Dec 2016 New trial record
- 01 Nov 2016 Primary endpoint (Target lesion failure at 1 month) has been met according to the results published in the Journal of the American College of Cardiology.
- 01 Nov 2016 Results published in the Journal of the American College of Cardiology